Lantheus Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

100.00$ -0.2% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

Lantheus Holdings Inc (LNTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 388 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LNTH
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	73	74	81	89	80	81	83	86	89	86	87	86	86	89	91	66	89	94	93	101	102	130	209	224	239	263	301	322	320	354	370	394	379	391	373	378	384	407	377	388	1,556
Cost of Revenue	39	40	42	43	41	43	40	42	44	42	42	41	44	45	53	40	52	56	51	55	59	72	80	86	92	96	224	119	120	124	118	138	137	143	135	137	162	166	146	146	620
Gross Profit	34	35	40	46	39	38	42	44	45	44	44	45	42	45	38	26	36	39	41	46	43	58	129	138	147	167	77	203	200	230	252	256	242	249	238	241	222	241	231	242	936
Research & Development	2.8	3.7	5.4	5.2	3.6	4.0	4.0	4.2	4.3	4.6	4.9	5.8	4.9	4.4	4.0	4.4	12	13	10	12	11	11	12	15	13	272	31	16	14	17	48	61	24	35	36	45	48	47	39	38	173
Selling, General & Administrative	10	10.0	12	11	12	14	13	12	14	12	13	13	18	17	17	21	18	14	16	43	29	63	38	33	24	40	23	26	36	40	48	47	41	58	57	67	82	70	58	21	230
Total Operating Expenses	22	22	28	28	26	29	27	28	28	27	28	30	33	32	31	31	42	39	25	73	57	93	70	75	62	339	86	79	88	92	151	153	108	135	136	153	179	164	150	142	634
Operating Income	13	12	12	18	13	9.2	15	16	16	17	16	15	8.5	12	7.1	-5.5	-5.3	-0.5	16	-27	-14	-35	59	63	86	-172	-9.3	124	112	137	100	103	134	114	102	88	44	77	81	100	302
Interest Expense	6.8	5.8	5.4	4.3	4.4	4.3	4.1	4.3	4.4	4.6	4.6	4.5	2.4	2.1	1.9	1.9	2.8	2.8	2.7	1.9	1.6	1.5	1.5	1.5	1.6	2.6	5.0	4.9	5.1	5.0	4.9	4.9	4.9	5.0	4.8	4.9	5.0	5.1	4.9	4.9	20
Pre-Tax Income	4.2	5.7	4.9	14	9.3	11	12	12	13	13	13	8.1	5.4	2.4	5.5	-6.7	-7.5	-2.8	14	-29	-20	-41	58	62	83	-176	-11	124	160	138	171	84	176	-0.8	97	105	42	70	156	94	363
Income Tax Expense	0.0	0.9	0.8	0.6	0.8	-86	3.8	2.2	3.6	-0.6	2.8	1.7	0.5	-8.1	2.2	0.3	-1.1	0.6	5.3	-1.9	-6.4	-0.8	15	19	22	-57	-8.3	30	28	35	40	22	45	11	24	26	15	16	38	19	88
Net Income	4.2	4.9	4.1	14	8.5	97	8.2	9.7	9.3	13	9.9	6.4	4.9	10	3.3	-7.0	-6.4	-3.4	9.0	-27	-13	-40	43	43	61	-119	-2.8	94	132	103	131	62	131	-12	73	79	28	54	118	75	275
EBITDA	15	17	17	24	17	20	20	20	21	21	21	16	11	8.1	11	-0.8	3.9	8.4	25	-17	-5.9	-27	71	76	97	-162	8.5	144	180	158	192	104	198	22	115	123	68	98	184	115	465

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings